Table 2. Three isolates selected for time-kill assay and their combination results at 24 h.
| Isolates, antimicrobials + concentrations (µg) | Effects of antibiotic combination, log change = (logCFU24 − logCFU0) | ||
|---|---|---|---|
| CREC4 | CREC5 | CREC7 | |
| T0.25 + P0.25 | 2.1 | 0.5 | −0.2* |
| T0.25 + P1 | −0.8* | −1.9* | −0.3* |
| T0.25 + A8 | 1.4 | 2.5 | 4.5 |
| T0.25 + A16 | −2* | 0.5 | 4.3 |
| T0.25 + M4 | 2 | 2 | 3.5 |
| T0.25 + M16 | 1.9 | 1.9 | 3.2 |
| T0.25 + L6.8 | 2.5 | 1 | 3.5 |
| T1 + P0.25 | −1.2* | −2.2* | −0.8* |
| T1 + P1 | −1.5* | −5.5* | −1* |
| T1 + A8 | −5.5* | −0.9* | 4.2 |
| T1 + A16 | −5.5* | −1.2* | 4.1 |
| T1 + M4 | −0.2* | 2 | 3 |
| T1 + M16 | −2.2* | 1.5 | 2.5 |
| T1 + L6.8 | 2.5 | 1 | 3.3 |
| P0.25 + A8 | 0.3* | −1.7* | 4.5 |
| P0.25 + A16 | −5.5* | −5.5* | 4.3 |
| P0.25 + M4 | 2.4 | 1 | 3.5 |
| P0.25 + M16 | 1.5 | 0.5 | 3.1 |
| P0.25 + L6.8 | 1.5 | −1.9 | 1.8 |
| P1 + A8 | no | −5.5* | 4.1 |
| P1 + A16 | no | no | 3.5 |
| P1 + M4 | 2.3 | −0.5 | 2.5 |
| P1 + M16 | 1.5 | −0.7 | 2.5 |
| P1 + L6.8 | 1 | −2 | −2.5* |
*, indicates a synergistic combination. PMB or TGC (0.25 and 1 µg/mL); MEM (4 and 16 µg/mL); and AMK (8 and 16 µg/mL) and LEV 6.8 µg/mL. No: since the low concentration can play a bactericidal effect, there is no synergistic killing experiment at this concentration. CREC, carbapenem-resistant Enterobacter cloacae; PMB, polymyxin B; TGC, tigecycline; MEM, meropenem; AMK, amikacin; LEV, levofloxacin.